CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has commenced …
CAMBRIDGE, Mass., March 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an …
LEAPs, or Long-Term Equity Participation Securities, are a fancy name for a stock option with a maturity of more than one year. A LEAP gives its owner the right to "exercise" the option to buy or sell 100 shares of stock at a set price for a …
After finishing off 2017 with a bang (the stock rallied from $32 to $40 in a just a few months), telecom giant AT&T Inc. (NYSE:T) has had a rough start to 2018. While the S&P 500 has partied its way to a 7% gain so far in 2018, T stock